Pharma Stocks
-
Astellas Pharma’s (TSE:4503) Earnings May Just Be The Starting Point
Even though Astellas Pharma Inc.’s (TSE:4503) recent earnings release was robust, the market didn’t seem to notice. Our analysis suggests…
Read More » -
Alnylam Pharmaceuticals, Inc. (ALNY) and GENESIS Pharma Expand Commercial Partnership
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On.…
Read More » -
IT selloff drags Nifty below 24,000; pharma stocks buck the trend
Markets turned sharply lower by midday on Tuesday, with the Nifty 50 slipping below the crucial 24,000 mark after early…
Read More » -
USFDA appeal for critical cancer drugs puts these Indian Pharma shares in focus
Shares of three pharmaceutical companies Cipla Ltd., Alkem Laboratories Ltd. and Zydus Lifesciences Ltd. are in focus on Tuesday, June…
Read More » -
What Signal Does It Send?
Vertex Pharmaceuticals experienced a strong upward movement and significant intraday volatility, driven by a combination of positive institutional data disclosures,…
Read More » -
AbbVie and Merck Face-Off: Which Pharma Stock Has the Lead? – June 22, 2026
Key Takeaways AbbVie’s Skyrizi and Rinvoq are driving growth and are expected to exceed $31 billion in sales in 2026.…
Read More » -
Aurobindo Pharma shares in focus after Eugia Steriles unit gets USFDA observations
Shares of Aurobindo Pharma Ltd. will be in focus on Monday, June 22, after the company disclosed the outcome of…
Read More » -
Pharma Momentum Fuels Johnson & Johnson’s Path to Double-Digit Upside
Quick Read JNJ earns a BUY rating with a $262 price target, representing 11% upside from current levels backed by…
Read More » -
Pharma Momentum Fuels Johnson & Johnson’s Path to Double-Digit Upside
© Mario Tama / Getty Images News via Getty Images Our Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) 24/7…
Read More » -
InnoCare Pharma (SEHK:9969) Stock Could Be 45% Undervalued After EHA 2026 Data
Why InnoCare Pharma Stock Is In Focus After EHA 2026 InnoCare Pharma (SEHK:9969) has drawn fresh attention after presenting data…
Read More »